These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8148751)

  • 1. Gender differences in needle sharing behaviour patterns.
    Smyth B; Keenan E; Dorman A; O'Connor JJ
    Addiction; 1994 Jan; 89(1):96-7. PubMed ID: 8148751
    [No Abstract]   [Full Text] [Related]  

  • 2. Once more unto the breach: controlling hepatitis C in injecting drug users.
    Wodak A; Crofts N
    Addiction; 1996 Feb; 91(2):181-4. PubMed ID: 8835275
    [No Abstract]   [Full Text] [Related]  

  • 3. Do female injectors under-utilize needle exchanges?
    Elliott L; Gruer L; Farrow K; Cameron J
    Addiction; 1994 Jan; 89(1):97-8. PubMed ID: 8148752
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV risk and the overlap of injecting drug use and high-risk sexual behaviours among men who have sex with men in Zanzibar (Unguja), Tanzania.
    Johnston LG; Holman A; Dahoma M; Miller LA; Kim E; Mussa M; Othman AA; Kim A; Kendall C; Sabin K
    Int J Drug Policy; 2010 Nov; 21(6):485-92. PubMed ID: 20638262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline findings from the third collaborative injection drug users study/drug users intervention trial (CIDUS III/DUIT).
    Booth RE; Strathdee SA
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S1-3. PubMed ID: 17889451
    [No Abstract]   [Full Text] [Related]  

  • 6. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatitis C epidemic, shall we remain silent?
    Paredes A; Zweben JE
    J Addict Dis; 2001; 20(1):1-7. PubMed ID: 11286427
    [No Abstract]   [Full Text] [Related]  

  • 8. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.
    Shaw SY; Shah L; Jolly AM; Wylie JL
    Addiction; 2007 Oct; 102(10):1626-35. PubMed ID: 17854339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in injection risk behaviors at the first injection episode.
    Frajzyngier V; Neaigus A; Gyarmathy VA; Miller M; Friedman SR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):145-52. PubMed ID: 17276623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inmates in Irish prisons face drug abuse and disease.
    Birchard K
    Lancet; 1999 Aug; 354(9180):753. PubMed ID: 10475200
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China.
    Wu Z; Luo W; Sullivan SG; Rou K; Lin P; Liu W; Ming Z
    AIDS; 2007 Dec; 21 Suppl 8():S115-22. PubMed ID: 18172379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
    Zamani S; Radfar R; Nematollahi P; Fadaie R; Meshkati M; Mortazavi S; Sedaghat A; Ono-Kihara M; Kihara M
    Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin.
    Smyth BP; O'Connor JJ; Barry J; Keenan E
    J Epidemiol Community Health; 2003 Apr; 57(4):310-1. PubMed ID: 12646549
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug, sex and sociality: factors associated with the recent sharing of injecting equipment among gay and bisexual men in Australia.
    Hopwood M; Lea T; Aggleton P
    Int J Drug Policy; 2015 Feb; 26(2):210-3. PubMed ID: 25480395
    [No Abstract]   [Full Text] [Related]  

  • 16. [Widespread risk behavior among injecting drug users. Over 80 percent HCV-infected--7 percent have HIV, as demonstrated by the first baseline study].
    Hillgren K; Sarkar K; Elofsson S; Britton S
    Lakartidningen; 2012 Jun 19-26; 109(25):1221-5. PubMed ID: 22838111
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV risk behaviour in Irish intravenous drug users.
    Dorman A; Keenan E; Schuttler C; Merry J; O'Connor JJ
    Ir J Med Sci; 1997; 166(4):235-8. PubMed ID: 9394073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users.
    Novelli LA; Sherman SG; Havens JR; Strathdee SA; Sapun M
    Drug Alcohol Depend; 2005 Mar; 77(3):303-9. PubMed ID: 15734230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV rate high in Baltimore.
    AIDS Patient Care STDS; 1999 Sep; 13(9):571. PubMed ID: 10813045
    [No Abstract]   [Full Text] [Related]  

  • 20. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.